Skip to main content
Top

16-03-2024 | Iron Deficiency Anemia | Original Article

Roles of ghrelin, hepcidin and HIF-2α in iron metabolism in iron deficiency anemia

Authors: Esra Rizaogullari Guzel, Nihan Cansel Sarkaya, Ayşegul Ugur Kurtoglu, Volkan Karakus, Erdal Kurtoglu

Published in: Irish Journal of Medical Science (1971 -)

Login to get access

Abstract

Objectives

This study investigates the roles of HIF-2α, hepcidin, and ghrelin in iron deficiency anemia (IDA), the most widespread nutritional disorder globally.

Material and methods

Fifty IDA patients (18–50 years, BMI 19–25) and 40 healthy volunteers were studied. Hemoglobin, ferritin, hepcidin, HIF-2α, and ghrelin levels were analyzed.

Results

IDA patients showed lower hemoglobin, ferritin, hepcidin, and ghrelin levels than the control group, but HIF-2α levels were similar. Positive correlations were observed in both groups between hepcidin and HIF-2α (p < 0.001), hepcidin and ghrelin (p < 0.001), and HIF-2α and ghrelin (p < 0.001). Hemoglobin was correlated positively with HIF-2α, and ferritin was correlated positively with HIF-2α in the patient group.

Conclusion

The study suggests that the low hepcidin levels in IDA patients enhance iron absorption. The lack of significant HIF-2α level differences may be due to the absence of chronic hypoxia in current hemoglobin levels of IDA patients. Moreover, the low ghrelin levels in patients and the correlations between ghrelin, hepcidin, and HIF-2α in both groups indicate their involvement in iron metabolism.
Literature
12.
go back to reference Organization WH (2001) Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. World Health Organization Organization WH (2001) Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. World Health Organization
Metadata
Title
Roles of ghrelin, hepcidin and HIF-2α in iron metabolism in iron deficiency anemia
Authors
Esra Rizaogullari Guzel
Nihan Cansel Sarkaya
Ayşegul Ugur Kurtoglu
Volkan Karakus
Erdal Kurtoglu
Publication date
16-03-2024
Publisher
Springer International Publishing
Published in
Irish Journal of Medical Science (1971 -)
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-024-03655-z
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine